Search Results 1051-1060 of 17711 for corticosteroid

1. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

   Subjects with a condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications ...

2. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid release therapy for adrenal or pituitary insufficiency) is not considered a form of ...

3. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Use of more than low dose corticosteroids ... Joint injections (e.g. arthritis) Doses of corticosteroid should be stable for at least 7 days prior to registration.

4. GPS Compared With BAT in AML CR2/CR2p - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...

5. A Study to Evaluate Inflammation of the Heart Muscle Tissue in Patients with Rheumatoid Arthritis - Mayo Clinic

   Prednisone > 10mg per day (or equivalent corticosteroid dose per day within last week). Irregular heart rhythm (arrhythmia or cardiac conduction abnormality ...

6. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   ... corticosteroids within the previous 12 months. History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced ...

7. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   If on a systemic corticosteroid, the dose must be stable for the previous 4 weeks ... Ongoing systemic immunosuppressive therapy other than corticosteroids ...

8. A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib to To Treat Newly-diagnosed AML with or without FLT3 Mutations - Mayo Clinic

   - Corticosteroids (any route) - Intrathecal therapy given at diagnosis - In particular, strong inducers of CYP3A4 and/or P-glycoprotein (P-gp) should be

9. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

   years (i.e., use of disease modifying agents, corticosteroids or immunosuppressive ... Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid

10. Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep - Mayo Clinic

    Stable dosage and stable time of intake of at least 1 and up to 3 antiseizure medications (ASMs) excluding systemic corticosteroids and intravenous ...